23 November 2022
CAP-XX Limited
("CAP-XX" or the "Company")
R&D Tax Rebate
CAP-XX Limited,a world leader in the design and manufacture of supercapacitors and energy management systems, is pleased to announce that following an application by the Company, the Australian Tax Office has advised that it has approved the Company's R&D tax rebate, amounting to A$2.05 million (November 2021: A$3.23 million) and these funds have been received by the Company.
For further information contact:
CAP-XX Limited
Anthony Kongats (Chief Executive Officer) +61 (0) 2 9428 0139
Allenby Capital (Nominated Adviser and Joint Broker)
David Hart / Alex Brearley (Corporate Finance) +44 (0) 20 3328 5656
Tony Quirke (Sales and Corporate Broking)
Cenkos Securities plc (Joint Broker)
Neil McDonald / Pete Lynch +44 (0) 13 1220 6939
Kreab (Financial PR)
Robert Speed +44 (0) 20 7074 1800
More information is available atwww.cap-xx.com
About CAP-XX
CAP-XX (LSE:CPX) is a world leader in the design and manufacture of ultra-thin prismatic and compact cylindrical supercapacitors. Its prismatic supercapacitors are manufactured in Australia and Malaysia and its cylindrical supercapacitors are manufactured in China. The company's strong intellectual property (IP) portfolio includes 11 patent families. CAP-XX's ultra-thin prismatic supercapacitors are ideal for space-constrained electronics applications where small energy storage device size and thickness are important. The unique feature of CAP-XX supercapacitors is their very high-power density and high-energy storage capacity in space-efficient thin prismatic and compact cylindrical packages. For more information, visithttps://www.cap-xx.com/or [email protected].
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. ENDMSCPPGQWGUPPPGP